The U.S. government on Tuesday named the 15 new drugs targeted for Medicare price negotiations for 2028, including Gilead ...

The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...

Big companies lost $96 billion in market capitalization after Medicare proposed a relatively flat rate increase for next year ...

Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...

The S&P 500 notched a record closing high and its fifth straight day of gains ​on Tuesday with a mixed reception to the ...

U.S. health insurer shares slumped on Tuesday, on track to erase about $80 billion in combined market value, after ​the Trump ...

Shares of large Medicare plan providers Humana, CVS Health and UnitedHealth Group plunged in extended trading.

Medicare Advantage (MA) plans and the providers in their networks are crying foul over potentially getting virtually no ...

Jan 27 (Reuters) - The U.S. Centers for Medicare & Medicaid Services on Tuesday named a new group of branded drugs from major ...

Shares of major insurers were hit hard after The Wall Street Journal reported the Trump administration was proposing roughly ...

The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Medicare picks Botox and Trulicity for latest round of negotiations The Centers for ...